In the MPNST group, 44 cfDNA samples were collected across multiple timepoints: at diagnosis (n = 13), during routine NF1 surveillance or treatment (n = 18), and at clinical recurrence (n=13). Here, NF1 is linked to malignant peripheral nerve sheath tumor.